RanD S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RanD S.p.A. - overview
Established
1999
Location
Modena, -, Italy
Primary Industry
Medical Devices & Equipment
About
Based in Modena, Italy, and founded in 1999, RanD S. p. A. operates as a manufacturing company that manufactures medical devices.
In July 2024, Continental Investment Partners acquired a majority stake in RanD S. p. A. RanD designs and manufactures medical devices for chemotherapy.
The company’s product line includes Performer LRT, which is a device for extracorporeal circulation therapies; Performer CPB, which is a heart-lung machine; Performer 3, designed for hyperthermic intra-peritoneal perfusion (HIPEC) treatment; and Performer HT, a device used for hyperthermic perfusion in surgical oncology. In addition, the company offers perfusion services, including clinical support for chemo-hyperthermia procedures. Following the July 2024 acquisition, the company plans for international expansion and the development of new products.
Current Investors
Continental Investment Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Oncology/Cancer Treatment, Diagnostic Equipment, Monitoring Equipment
Website
https://rand-biotech.com/
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
RanD S.p.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LP Direct | Completed | RanD S.p.A. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.